What this means
This is a trial that is still recruiting people, and no results have been shared yet. It does not tell us anything about what the vaccine does yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 21 and over
- Where
- 1 site, including New York
The science
- Registered title
- The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
- Trial ID
- NCT06128915 ↗
- Phase
- PHASE 4
- Study type
- interventional
- Conditions
- Aging
- What is tested
- vaccine
- Sponsor
- State University of New York at Buffalo
- Ages
- 21 Years to no maximum
- Dates
- First posted Nov 13, 2023 · updated Apr 3, 2026
Registry summary
This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar-13 in young and elderly adults.
Sites (1)
- University at Buffalo, Buffalo, New York, United States